Acadia Pharmaceuticals INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Acadia Pharmaceuticals has released its proxy statement for the 2025 Annual Meeting of Stockholders, detailing director elections, executive compensation, and auditor ratification.
NASDAQ
DEF 14A: Acadia Pharmaceuticals Outlines Executive Compensation and Governance in 2024 Proxy Statement
Acadia Pharmaceuticals' 2024 proxy statement details executive compensation, board structure, and key proposals for the upcoming annual meeting.